At RG+A, we have earned a reputation as an innovative provider of insights-based consulting for healthcare product commercialization. We have partnered with a range of biotechnology, pharmaceutical, and medical device companies to support strategic decision-making related to pricing optimization, product valuation, contracting strategy development, endpoint design and value positioning, and demand forecasting. In the late 1990s, we developed Dynamic Practice Simulation® (DPS®), the industry’s first major patient-simulating quantitative research system. Since that time, we have expanded our methods to include leading-edge qualitative, quantitative, and modeling methods. By combining practical focus, superior methodology, and tireless commitment to our core principles, RG+A competes consistently and successfully with the largest research firms in healthcare marketing research and consulting.
Global Research Experience
We have conducted primary research in a multitude of markets around the world.
United States • Canada • Mexico • Argentina • Brazil • Chile • France • Germany • Greece • Italy • Spain • United Kingdom • Australia • New Zealand and more